Monte Rosa Therapeutics (GLUE) Shares Outstanding (Entity) (2020 - 2026)
Monte Rosa Therapeutics (GLUE) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 139.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.54 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 214.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 113.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 575.47 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.73 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 218.28 Mn |
| 10 | Monte Rosa Therapeutics | 1.32 Bn | 688.11 Mn | - | 85.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.31 Mn |
| Mar 31, 2026 | 84.32 Mn |
| Dec 31, 2025 | 83.07 Mn |
| Sep 30, 2025 | 82.40 Mn |
| Jun 30, 2025 | 82.19 Mn |
| Mar 31, 2025 | 82.15 Mn |
| Dec 31, 2024 | 61.51 Mn |
| Sep 30, 2024 | 82.01 Mn |
| Jun 30, 2024 | 61.33 Mn |
| Mar 31, 2024 | 50.21 Mn |
| Dec 31, 2023 | 50.15 Mn |
| Sep 30, 2023 | 50.09 Mn |
| Jun 30, 2023 | 49.64 Mn |
| Mar 31, 2023 | 49.45 Mn |
| Dec 31, 2022 | 49.45 Mn |
| Sep 30, 2022 | 48.37 Mn |
| Jun 30, 2022 | 46.68 Mn |
| Mar 31, 2022 | 46.63 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Sep 30, 2021 | 46.48 Mn |